英国生物银行中自伤个体风险因素的多基因评分与孟德尔随机化研究
基于24项GWAS汇总数据构建多基因评分,在125,925名完成在线心理健康问卷的英国生物银行参与者中分析24种个体风险因素与自伤的关系,发现6种多基因评分可预测自伤,孟德尔随机化提示重性抑郁障碍、注意缺陷/多动障碍和精神分裂症是最可能的因果风险因素。
核心结论
- 除证实重性抑郁障碍的作用外,多变量遗传设计提示注意缺陷/多动障碍和精神分裂症也可能参与自伤病因。
- 系统检测和治疗核心精神症状(包括精神病性症状和冲动症状)可能对自伤风险人群有益。
研究设计与样本
- 利用24项全基因组关联研究的汇总统计(16,067至322,154名个体)生成多基因评分,索引24种可能的个体风险因素。
- 在125,925名(56.2%女性)完成在线心理健康问卷的英国生物银行参与者中,采用二项回归模型分析多基因评分与自伤的关系。
- 进一步采用两样本孟德尔随机化分析探究因果关系。
主要发现
- 5,520名(4.4%)参与者报告终生自伤。
- 6种多基因评分(重性抑郁障碍、注意缺陷/多动障碍、双相障碍、精神分裂症、酒精依赖障碍和终生大麻使用)可预测自伤,效应量从终生大麻使用的OR=1.05(95%CI 1.02至1.07,q=0.008)到重性抑郁障碍的OR=1.20(95%CI 1.16至1.23,q=1.33×10⁻³⁵)。
- 自杀性与非自杀性自伤之间未出现系统性差异。
- 孟德尔随机化分析中,重性抑郁障碍、注意缺陷/多动障碍和精神分裂症是最可能的因果风险因素。
- 重性抑郁障碍和精神分裂症的遗传易感性与自伤的关联独立于诊断和用药。
临床怎么用
- 对自伤风险人群可考虑系统检测和治疗核心精神症状,包括精神病性症状和冲动症状。
局限性
- 英国生物银行样本缺乏代表性。
- 自伤为自我报告。
- 部分纳入的GWAS统计效力有限,可能导致II类错误。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Identifying causal risk factors for self-harm is essential to inform preventive interventions. Epidemiological studies have identified risk factors associated with self-harm, but these associations can be subject to confounding. By implementing genetically informed methods to better account for confounding, this study aimed to better identify plausible causal risk factors for self-harm. METHODS AND FINDINGS: Using summary statistics from 24 genome-wide association studies (GWASs) comprising 16,067 to 322,154 individuals, polygenic scores (PSs) were generated to index 24 possible individual risk factors for self-harm (i.e., mental health vulnerabilities, substance use, cognitive traits, personality traits, and physical traits) among a subset of UK Biobank participants (N = 125,925, 56.2% female) who completed an online mental health questionnaire in the period from 13 July 2016 to 27 July 2017. In total, 5,520 (4.4%) of these participants reported having self-harmed in their lifetime. In binomial regression models, PSs indexing 6 risk factors (major depressive disorder [MDD], attention deficit/hyperactivity disorder [ADHD], bipolar disorder, schizophrenia, alcohol dependence disorder, and lifetime cannabis use) predicted self-harm, with effect sizes ranging from odds ratio (OR) = 1.05 (95% CI 1.02 to 1.07, q = 0.008) for lifetime cannabis use to OR = 1.20 (95% CI 1.16 to 1.23, q = 1.33 × 10-35) for MDD. No systematic differences emerged between suicidal and non-suicidal self-harm. To further probe causal relationships, two-sample Mendelian randomisation (MR) analyses were conducted, with MDD, ADHD, and schizophrenia emerging as the most plausible causal risk factors for self-harm. The genetic liabilities for MDD and schizophrenia were associated with self-harm independently of diagnosis and medication. Main limitations include the lack of representativeness of the UK Biobank sample, that self-harm was self-reported, and the limited power of some of the included GWASs, potentially leading to possible type II error. CONCLUSIONS: In addition to confirming the role of MDD, we demonstrate that ADHD and schizophrenia likely play a role in the aetiology of self-harm using multivariate genetic designs for causal inference. Among the many individual risk factors we simultaneously considered, our findings suggest that systematic detection and treatment of core psychiatric symptoms, including psychotic and impulsivity symptoms, may be beneficial among people at risk for self-harm.
引用
- Lim KX, Rijsdijk F, Hagenaars SP, et al. Studying individual risk factors for self-harm in the UK Biobank: A polygenic scoring and Mendelian randomisation study. PLoS Med. 2020. PMID: 32479557. doi:10.1371/journal.pmed.1003137
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。